Brief: Fresh Tracks Therapeutics Publishes Preclinical Data For FRTX-02
11/01/2023 13:46
Jan 11 (Reuters) - Fresh Tracks Therapeutics Inc
FRTX.O :
* FRESH TRACKS THERAPEUTICS ANNOUNCES PUBLICATION OF
PRECLINICAL
DATA FOR FRTX-02, A POTENTIAL FIRST-IN-CLASS ORAL DYRK1A
INHIBITOR, IN PEER-REVIEWED JOURNAL OF TRANSLATIONAL
AUTOIMMUNITY
Source text for Eikon: ID:nGNX2pZqvV
Further company coverage: FRTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fresh Tracks Therapeutics
See all newsBrief: Fresh Tracks Therapeutics Announces Second Adjournment Of Special Meeting Of Stockholders
Brief: Fresh Tracks Therapeutics Intends To Seek Judicial Dissolution If Liquidation And Approved By Stockholders
Brief: Fresh Tracks Therapeutics Q3 EPS USD 0.32
Brief: Fresh Tracks Therapeutics Inc On October 10 Received A Notice From Listing Qualifications Department Of Nasdaq
U.S. STOCKS ON THE MOVE-Gold miners, Goosehead Insurance, FedEx